Furthermore, STMN1 overexpression is associated with upregulation of FOXM1 in patients with advanced non-small cell lung cancer, and STMN1/FOXM1 upregulation leads to poor prognosis [34]. The gene discussed is STMN1; the disease is non-small cell lung carcinoma.